Cell and Tissue Engineering

  1. Clinical Translation and Regulation
    1. Regulatory Framework
      1. United States Regulation
        1. Food and Drug Administration
          1. Investigational New Drug Application
            1. Premarket Approval
              1. 510(k) Clearance
              2. European Regulation
                1. European Medicines Agency
                  1. Advanced Therapy Medicinal Products
                    1. CE Marking
                    2. Product Classification
                      1. Medical Devices
                        1. Biologics
                          1. Combination Products
                            1. Drug-Device Combinations
                          2. Manufacturing Standards
                            1. Good Manufacturing Practices
                              1. Facility Requirements
                                1. Personnel Training
                                  1. Equipment Validation
                                  2. Quality Control
                                    1. Raw Material Testing
                                      1. In-Process Testing
                                        1. Final Product Testing
                                        2. Quality Assurance
                                          1. Documentation Systems
                                            1. Change Control
                                              1. Corrective Actions
                                              2. Traceability
                                                1. Batch Records
                                                  1. Component Tracking
                                                    1. Patient Tracking
                                                  2. Clinical Development
                                                    1. Preclinical Studies
                                                      1. In Vitro Testing
                                                        1. Animal Studies
                                                          1. Safety Assessment
                                                          2. Clinical Trial Design
                                                            1. Phase I Trials
                                                              1. Phase II Trials
                                                                1. Phase III Trials
                                                                2. Patient Selection
                                                                  1. Inclusion Criteria
                                                                    1. Exclusion Criteria
                                                                      1. Risk-Benefit Assessment
                                                                      2. Outcome Measures
                                                                        1. Primary Endpoints
                                                                          1. Secondary Endpoints
                                                                            1. Safety Endpoints
                                                                          2. Commercialization
                                                                            1. Market Access
                                                                              1. Reimbursement Strategies
                                                                                1. Health Technology Assessment
                                                                                  1. Payer Negotiations
                                                                                  2. Manufacturing Scale-Up
                                                                                    1. Process Development
                                                                                      1. Technology Transfer
                                                                                        1. Cost of Goods
                                                                                        2. Supply Chain Management
                                                                                          1. Cold Chain Requirements
                                                                                            1. Distribution Networks
                                                                                              1. Inventory Management
                                                                                              2. Intellectual Property
                                                                                                1. Patent Strategy
                                                                                                  1. Freedom to Operate
                                                                                                    1. Licensing Agreements
                                                                                                  2. Ethical Considerations
                                                                                                    1. Human Tissue Use
                                                                                                      1. Tissue Banking
                                                                                                        1. Donor Rights
                                                                                                        2. Stem Cell Ethics
                                                                                                          1. Embryonic Stem Cells
                                                                                                            1. Induced Pluripotent Stem Cells
                                                                                                              1. Research Guidelines
                                                                                                              2. Patient Safety
                                                                                                                1. Risk Assessment
                                                                                                                  1. Adverse Event Reporting
                                                                                                                    1. Long-Term Monitoring
                                                                                                                    2. Access and Equity
                                                                                                                      1. Cost Considerations
                                                                                                                        1. Global Access
                                                                                                                          1. Healthcare Disparities

                                                                                                                      Previous

                                                                                                                      8. Characterization and Evaluation

                                                                                                                      Go to top

                                                                                                                      Next

                                                                                                                      10. Emerging Technologies and Future Directions